South
Korea conducts experimental plasma therapy on MERS
patients
Send a link to a friend
[June 16, 2015]
By Jack Kim
SEOUL (Reuters) - Two South Korean
hospitals are conducting experimental treatment on Middle East
Respiratory Syndrome (MERS) patients, injecting them with blood plasma
from recovering patients, the health ministry said on Tuesday, as four
new cases were reported.
|
The procedure has been conducted on two consenting MERS patients in
addition to existing care, the ministry's head of public health
policy, Kwon Jun-wook, told a media briefing.
"There is insufficient clinical basis about the result of plasma
treatment among experts in the country," Kwon said, but added: "The
ministry has deep confidence in the medical staff on the direction
of the treatment."
Plasma treatment was previously used in SARS patients with some
positive results in seriously ill patients that led to a decrease in
the death rate by up to 23 percent, Kwon said.
Plasma therapy has not been widely tried for MERS patients, with
little clinical study results reported, Eom Joong-sik, professor of
infectious diseases at Hallym University's medical college.
Three years after the MERS virus first emerged in humans, there is
no cure or vaccine that can protect people from falling sick with
it, and little work has been done in develop a vaccine, despite
considerable available scientific detail.
![](http://archives.lincolndailynews.com/2015/Jun/16/images/ads/current/gives_you_more_bch_040314.png)
South Korea first confirmed MERS on May 20.
Four new cases were reported on Tuesday, bringing the total to 154
in the South Korean outbreak, the largest outside Saudi Arabia. The
ministry also said three more patients with MERS had died, taking
the South Korean death toll to 19.
The World Health Organization (WHO) has called the South Korean
outbreak "large and complex" and all MERS cases have been traced to
healthcare facilities.
The health ministry has put more than 5,500 people in quarantine, at
home or in health facilities.
[to top of second column] |
![](../images/ads/current/Symphony_122313.png)
MERS is caused by a coronavirus from the same family as the one that
triggered China's deadly 2003 outbreak of Severe Acute Respiratory
Syndrome (SARS).
The vast majority of MERS infections and deaths have been in Saudi
Arabia, where more than 1,000 people have been infected since 2012,
and some 454 have died.
The number of new MERS cases in South Korea continued to be sharply
lower than last week, when the daily increase reached as high as 23.
The WHO, which conducted a review of South Korea's response last
week, said on Saturday the decline suggested control measures were
working.
The WHO has scheduled a meeting of its MERS emergency committee
later on Tuesday in Geneva to provide technical updates on
epidemiology and advice on future actions to be taken in response to
the outbreak.
(Additional reporting by Ju-min Park; Editing by Michael Perry)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
![](http://archives.lincolndailynews.com/2015/Jun/16/images/ads/current/charrons_bch041713.png) |